Actively Recruiting

Age: 45Years - 55Years
FEMALE
Healthy Volunteers
NCT06490146

Menopause Transition, Sex Hormone Deficiency and Autonomic and Vascular Function

Led by University of Minnesota · Updated on 2025-05-08

80

Participants Needed

1

Research Sites

281 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This is a longitudinal study to determine the influence of the menopause transition on autonomic and vascular function. PI Keller-Ross has published data demonstrating that postmenopausal females have greater sympathetic neural reactivity during a stressor compared with age-matched males and younger females and males. A paucity of literature exists, however, on the role of the menopause transition in autonomic function because the majority of experimental studies on menopause physiology are cross-sectional and/or focused on older, postmenopausal females . The influence of age on HTN is robust, whereas the effects of menopause are still unclear. Preliminary data demonstrate a clear association between age and sympathetic activity in females; how the transition through menopause influences these relations, however, remains unknown. The study will enroll 80 midlife (45-55 years of age) females to measure longitudinally the trajectory of autonomic and vascular function during the transition through menopause. The study hypothesizes that through the menopause transition, an increase in sympathetic activity and an impaired baroreflex sensitivity and endothelial function will emerge.

CONDITIONS

Official Title

Menopause Transition, Sex Hormone Deficiency and Autonomic and Vascular Function

Who Can Participate

Age: 45Years - 55Years
FEMALE
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Female
  • Age 45 to 55 years
  • Premenopausal
  • Not using medications that affect autonomic function
  • Having regular menstrual cycles (eumenorrheic)
  • Not planning to become pregnant during the study
  • English-speaking, literate, and able to provide informed consent
Not Eligible

You will not qualify if you...

  • Diabetes
  • Pregnant or breastfeeding
  • Cardiac or pulmonary disorders
  • Severe obesity (BMI 40 kg/m2 or higher)
  • Hypertension
  • Obstructive sleep apnea
  • Current use of heart or blood pressure medications
  • Current use of hormonal contraceptives or other exogenous sex hormones
  • Nicotine or tobacco use in the last six months
  • Current alcohol abuse
  • History of chemotherapy or radiation treatment
  • Coagulopathy disorders or use of anticoagulant medications
  • Current use of anxiolytics or antidepressants

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

University of Minnesota

Minneapolis, Minnesota, United States, 55414

Actively Recruiting

Loading map...

Research Team

E

Emma Lee, PhD

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Menopause Transition, Sex Hormone Deficiency and Autonomic and Vascular Function | DecenTrialz